Emotional Intelligence Ventures and Mycotopia enter a Definitive Agreement on $382M merger transaction
May 19, 2022
Ryan Allway May 19th, 2022 Psychedelics, Top News Entities on track to merge under PSLY.com and list on NASDAQ Stock Exchange MIAMI and MAUI, Hawaii, May 19, 2022 (GLOBE NEWSWIRE) — Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development... Read more
Real Brands Announces Entry to Medical Psychedelics Market, Partners with Marcu & Arora for Licensure, R&D
CBD March 24, 2022
Ryan Allway March 24th, 2022 Psychedelics, Top News Real Brands applying for DEA psychedelics licensure Psychedelics drugs market size is projected to reach $10.75 billion by 2027 Real Brands planning to leverage new clinical research to produce and deliver safe, nature-based psychedelics product formulations that will effectively treat mental... Read more
Irwin Naturals Begins Rollup of Psychedelic Mental Health Clinics
February 9, 2022
Ryan Allway February 9th, 2022 Psychedelics, Top News LOS ANGELES, Feb. 09, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today it has taken the first step in the execution of its ketamine clinic rollup strategy – a move... Read more
